AI assistant
Sending…
Anixa Biosciences Inc — Director's Dealing 2017
Sep 11, 2017
34117_dirs_2017-09-11_bfef1c7b-11a9-4ee6-9d39-4d3b6c85c04c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3/A — Form 3/A
Issuer: ITUS Corp (ITUS)
CIK: 0000715446
Period of Report: 2016-08-23
Reporting Person: MONAHAN JOHN J (Director)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) | $3.13 | 2026-08-23 | Common Stock (6000) | Direct |
Footnotes
F1: Right-To-Buy, pursuant to the ITUS Corporation 2010 Share Incentive Plan.
F2: The option vests and becomes exercisable 50% on September 30, 2016 and 50% on December 31, 2016.
F3: This Form 3/A is being filed to correct a typo in the expiration date column to reflect that the Employee Stock Option expires on August 23, 2026, not August 23, 2016.
More from Anixa Biosciences Inc
Regulatory Filings
2026
Mar 11
Interim / Quarterly Report
2026
Mar 9
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Jan 29
Proxy Solicitation & Information Statement
2026
Jan 28
Regulatory Filings
2026
Jan 12
Annual Report
2026
Jan 12
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6